Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Manufacturers’ Drug Discount Obligation Won’t Be Reduced In Part D Retiree Plans Under CMS Policy

Executive Summary

A new Medicare Part D policy on calculating the 50% discount on branded drugs in the coverage gap will not allow for reduced manufacturer payments when beneficiaries are enrolled in employer group waiver plans, despite arguments from drug firms.

You may also be interested in...



U.S. Postal Service Health Care Proposal Would Shift 480,000 Retirees Into Part D

The proposal to shift retirees into Medicare Part D is part of a broader plan to reduce health care costs at the struggling organization. It would also require all USPS retirees to enroll in Medicare Parts A and B.

Nursing Home Overprescribing: CMS Urges Voluntary Remedies, Withholds Regulation

CMS will not implement an earlier regulatory proposal requiring that consultant pharmacists maintain independence from long-term care facilities or drug firms at this point.

CMS Adopts Trial-Size Prescriptions For Part D, Delays Implementation

CMS mandates that Part D plans offer prescriptions filled for less than a 30-day period at a daily cost-sharing rate, with a few stated exceptions, but delays implementation until the 2014 plan year.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS054365

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel